BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hesperos Inc. - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hesperos Inc.
X-ORIGINAL-URL:https://hesperosinc.com
X-WR-CALDESC:Events for Hesperos Inc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20270314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20271107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250917
DTEND;VALUE=DATE:20250918
DTSTAMP:20260427T203307
CREATED:20250717T181110Z
LAST-MODIFIED:20250717T181110Z
UID:3178-1758067200-1758153599@hesperosinc.com
SUMMARY:Labroots Cell Biology Virtual Events Series 2025
DESCRIPTION:Labroots Cell Biology Virtual Events Series 2025\nInvited Speaker \nChristopher Long\, PhD \nSept. 17th\, on demand all day \nAbout the Labroots Cell Biology Virtual Event Series:  This virtual event provides a place for interdisciplinary exchange and knowledge-sharing opportunities.  Leading experts\, researchers\, and innovators will share breakthroughs and discuss the latest trends and methodologies in cell biology. \nRegister free to watch Dr. Long’s presentation at https://www.labroots.com/virtual-event/cell-biology-2025
URL:https://hesperosinc.com/event/labroots-cell-biology-virtual-events-series-2025/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/07/virtual_event_header_banner_image_c1b61b6e123bfc85a6861c6cb80fc78786ff698f_5153.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20250926
DTSTAMP:20260427T203307
CREATED:20250609T154351Z
LAST-MODIFIED:20250610T130827Z
UID:3124-1758499200-1758844799@hesperosinc.com
SUMMARY:23rd Annual Discovery on Target
DESCRIPTION:23rd Annual Discovery on Target\nSept. 22-25 \nInvited Speaker  \nJames Hickman\, PhD\, Hesperos Co-Founder and Chief Scientist \nRegulatory Acceptance of Human-on-a-Chip Platforms \nSept. 22\, 9:00 AM EST \nAbout Discovery on Target: This week long event in Boston\, MA showcases the latest research on current and emerging drug targets and technology.  There will be numerous presentations\, discussions\, and networking opportunities for those at the forefront of drug discovery. \nLearn more and register at https://www.discoveryontarget.com/
URL:https://hesperosinc.com/event/23rd-annual-discovery-on-target/
LOCATION:Sheraton Boston
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/06/DOT-banner-LI-standard-speaking-at-code.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251205
DTEND;VALUE=DATE:20251206
DTSTAMP:20260427T203307
CREATED:20251107T215334Z
LAST-MODIFIED:20251110T164829Z
UID:3363-1764892800-1764979199@hesperosinc.com
SUMMARY:The 3Rs Collaborative & IQ-Consortium: Microphysiological Systems Webinar & Workshop Series
DESCRIPTION:Webinar: Microphysiological Systems Webinar & Workshop Series\nWednesday\, December 3\, 2025\n10 am-12:30 p.m. (EST)\nInvited Speaker\nJ Hickman\, PhD\, Chief Scientist \n  \nAbout the webinar: 3RsC MPS in Drug Development program is an initiative by The 3Rs Collaborative (3RsC) to advance the adoption and regulatory acceptance of Microphysiological Systems (MPS) technologies\, in alignment with the principles of the 3Rs (Replacement\, Reduction\, and Refinement) in animal research. 
URL:https://hesperosinc.com/event/the-3rs-collaborative-iq-consortium-microphysiological-systems-webinar-workshop-series/
LOCATION:The Three Rs Collaborative\, United States
CATEGORIES:Invited Speaker,Webinar
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/11/Na3rc-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251205
DTEND;VALUE=DATE:20251206
DTSTAMP:20260427T203307
CREATED:20241212T195120Z
LAST-MODIFIED:20250703T193630Z
UID:2910-1764892800-1764979199@hesperosinc.com
SUMMARY:Hybrid Public Workshop: Pediatric Developmental Safety Assessment and Novel Alternative Methods
DESCRIPTION:Hybrid Public Workshop: Pediatric Developmental Safety Assessment and Novel Alternative Methods \nDec. 5th\, 2025 \nSilver Spring\, MD \nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \nAbout the Hybrid Public Workshop: Pediatric Developmental Safety Assessment and Novel Alternative Methods:  This free public workshop is organized by the CDER Office of Clinical Pharmacology and Triangle CERSI.  It will cover advances in pediatric drug development programs and New Approach Methodologies (NAMs) being used as alternatives to animal testing in pediatric preclinical assessments.
URL:https://hesperosinc.com/event/pediatric-developmental-safety-assessment-and-novel-alternative-methods/
LOCATION:FDA White Oak Campus
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/12/Event-Web-Page-Graphics-49.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260112T080000
DTEND;TZID=UTC:20260112T170000
DTSTAMP:20260427T203307
CREATED:20260112T014558Z
LAST-MODIFIED:20260112T014558Z
UID:3477-1768204800-1768237200@hesperosinc.com
SUMMARY:2026 - MPS World Summit
DESCRIPTION:Join us! \nMore info coming soon. \nClick here to register: https://mpsworldsummit.org/2026-registration-information/
URL:https://hesperosinc.com/event/2026-mps-world-summit/
LOCATION:Walter E. Washington Convention Center
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/01/Screenshot-2026-01-11-184339.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260122
DTEND;VALUE=DATE:20260124
DTSTAMP:20260427T203307
CREATED:20260112T013437Z
LAST-MODIFIED:20260119T182021Z
UID:3463-1769040000-1769212799@hesperosinc.com
SUMMARY:International Conference on Advances in 3D Cell Culture
DESCRIPTION:Invited Speaker\nJames Hickman\, Chief Scientist\, Hesperos Inc. \nPresentation:  Regulatory acceptance of human-on-a-chip systems for efficacy and safety \nJanuary 22-23\, 2026 \nFull Program Agenda\n3DCC26_ProgramAgenda_v2 \nLink to register: https://eventregister.mumbaibiocluster.org/ \n 
URL:https://hesperosinc.com/event/international_conference_advances_3d_cell_culture/
LOCATION:Novotel Dona Sylvia Resort\, Cavelossim Road Mobor\, Cavelossim\, GA\, Goa\, India
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/01/1767447014533-e1768846809456.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260205T110000
DTEND;TZID=UTC:20260205T120000
DTSTAMP:20260427T203307
CREATED:20260203T171253Z
LAST-MODIFIED:20260203T213343Z
UID:3507-1770289200-1770292800@hesperosinc.com
SUMMARY:Webinar:  Multi-organ human-on-a-chip systems for predicting drug efficacy and toxicity
DESCRIPTION:James J. Hickman\, Chief Scientist at Hesperos\, will be presenting at the upcoming webinar: Multi-organ human-on-a-chip systems for predicting drug efficacy and toxicity. Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation. \nA major challenge in drug discovery and toxicology is the gap between cell-level studies and whole-animal or human systems.  Researchers are now creating miniaturized human-on-a-chip systems where human-derived cells connect and function in ways that reflect real tissue and organ behavior\, enabling more accurate evaluation of drug efficacy and safety. \nIn this webinar\, James Hickman will discuss developing advanced multi-organ human-on-a-chip systems that model neural\, muscle\, and cardiac subsystems and how these platforms can inform preclinical decision-making. \nTopics to be covered: \n\nDesign\, fabrication\, and validation of multi-organ human-on-a-chip\nModeling motor\, cognitive\, muscle\, and cardiac functions\nApplications in preclinical drug discovery and toxicity testing\n\nClick HERE to register!
URL:https://hesperosinc.com/event/multi-organ-human-on-a-chip-systems-for-predicting-drug-efficacy-and-toxicity/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/02/DDN-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260322
DTEND;VALUE=DATE:20260326
DTSTAMP:20260427T203307
CREATED:20260304T195539Z
LAST-MODIFIED:20260320T144307Z
UID:3539-1774137600-1774483199@hesperosinc.com
SUMMARY:Join Hesperos at Society of Toxicology (SOT) 2026: Booth #846
DESCRIPTION:Visit Hesperos at SOT 2026 ToxExpo: Booth #846\nStop by and take the opportunity to discuss how Hesperos’ single and multi-organ Human-on-a-Chip® organ system models can help your organization better elucidate and understand your product’s profile. \n\nFeatured Presentations\n \n\nPoster Presentation: \n#H624: The Utilization of In Vitro\, Human on a Chip Cortical Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy \n\nPresented by: Rocky Brighton\nTuesday\, March 24\, 9:15am – 11:45am PT\nView Session Details\n\n\nPoster Presentation: \n#F505: Off target toxicity and efficacy testing of a novel stress reliever in a multi-organ microphysiological system \n\nPresented by: Christopher McAleer\, PhD\nWednesday\, March 25\, 9:15am – 11:45am PT\nView Session Details\n\n\n\n\n  \nView Hesperos SOT Booth #846
URL:https://hesperosinc.com/event/hesperos-at-sot-2026-booth-846/
LOCATION:San Diego Convention Center
CATEGORIES:Exhibitor,Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/03/SOT-Announcement-Graphic1200-x-700-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260409
DTSTAMP:20260427T203307
CREATED:20260403T171458Z
LAST-MODIFIED:20260403T171546Z
UID:3654-1775606400-1775692799@hesperosinc.com
SUMMARY:Hesperos Chief Scientist Presenting at Quantitative Systems Pharmacology Conference 2026​​​​​​​​​​​​​​​​​​
DESCRIPTION:Details:\nDate: 08 April 2026\nTime:  16:10 (UTC+2)\nSession 4: Integrating Micro-Physiological and Organ-on-Chip Systems with QSP \nHesperos\, Inc. is proud to announce that our Chief Scientist\, Dr. James J. Hickman\, will be a featured speaker at the upcoming Quantitative Systems Pharmacology Conference (QSPC) 2026 in Leiden\, Netherlands. This event brings together global leaders from academia\, industry\, and regulatory agencies to explore advances in quantitative systems pharmacology (QSP) and mechanism-based pharmacokinetics and pharmacodynamics (PK/PD).  \nPresentation:\n“Regulatory Acceptance of Microphysiological and Organ-on-Chip Systems”\nAs the drug discovery landscape shifts toward more human-relevant models\, the integration of microphysiological systems (such as our Human-on-a-Chip® single- and multi-organ system models) with QSP is becoming a critical bridge for translational success. In this talk\, Dr. Hickman will discuss the path toward regulatory acceptance for these platforms. \nSession 4 explores the synergy between organ-on-a-chip platforms and the mathematical frameworks of QSP including PK/PD. Among other topics\, attendees will gain a deeper understanding of: \n\nThe current status of MPS validation for regulatory use.\nHow Hesperos’ serum-free\, single and multi-organ platforms can be combined with QSP models.\nStrategies for utilizing human-relevant data to better inform and accelerate clinical development timelines.\n\nAbout the Speaker\nJames J. Hickman\, Ph.D.\, is the Chief Scientist and Co-Founder of Hesperos\, Inc. He is also the Founding Director of the NanoScience Technology Center at the University of Central Florida. A pioneer in the field\, Dr. Hickman has spent over 30 years developing functional in vitro systems. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE)\, the National Academy of Inventors\, and is the President of the International Microphysiological Systems Society (IMPSS). \n\nPlanning to attend QSPC 2026? We invite you to connect with Dr. Hickman to discuss how our Human-on-a-Chip® technology can support your drug development programs. \nLink to Registration and Full Program
URL:https://hesperosinc.com/event/hesperos-chief-scientist-presenting-at-quantitative-systems-pharmacology-conference-2026/
LOCATION:Stadsgehoorzaal\, Breestraat 60\, 2311 CS\, Leiden\, Leiden\, Netherlands
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/04/JH-Talk-QSPC-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260418
DTSTAMP:20260427T203307
CREATED:20260413T172611Z
LAST-MODIFIED:20260413T172611Z
UID:3678-1776384000-1776470399@hesperosinc.com
SUMMARY:Hesperos Presenting at the HNF CMT Summit 2026
DESCRIPTION:Date: 17 April 2026\nTime: 1:50 PM – 2:30 PM (EDT)\nEvent: HNF CMT Summit + Health & Wellness Retreat 2026\nLocation: Ellicott City\, Maryland \nHesperos\, Inc. is proud to announce that our Chief Scientist\, Dr. James J. Hickman\, will be a featured speaker at the upcoming HNF CMT Summit + Health & Wellness Retreat 2026 in Ellicott City\, Maryland. Hosted by the Hereditary Neuropathy Foundation (HNF)\, this event brings together global leaders from academia\, industry\, clinical practice\, and the patient community to explore the latest research and advancements in Charcot-Marie-Tooth (CMT) disease. \nPresentation – Research Track: AI & Technology Advances in CMT \nThe integration of artificial intelligence and microphysiological systems (such as our Human-on-a-Chip® single and multi-organ platform) are becoming a critical bridge for translational success in rare diseases\, including CMT. In this talk\, Dr. Hickman will discuss how these technologies will continue to benefit research and therapeutic development in this and other rare disease arenas. \nHighlights attendees can expect to explore include: \n\nHow artificial intelligence and cutting-edge\, human-relevant in vitro technologies are accelerating drug discovery and target identification for CMT and other rare diseases.\nThe role Hesperos’ serum-free\, multi-organ platforms have played modeling complex neuropathies and supporting therapeutic development\, including an example utilizing sera from an individual patient with CMT2A to evaluate efficacy of a potential therapeutic gaining an Orphan Drug Designation (See March 2025 Announcement).\n\nAbout the Speaker \nJames J. Hickman\, Ph.D.\, is the Chief Scientist and Co-Founder of Hesperos\, Inc. He is also the Founding Director of the NanoScience Technology Center at the University of Central Florida. A pioneer in the field\, Dr. Hickman has spent over 30 years developing functional in vitro systems. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE)\, the National Academy of Inventors\, and is the President of the International Microphysiological Systems Society (IMPSS). \nPlanning to attend the CMT Summit 2026? We invite you to connect with Dr. Hickman to discuss how our Human-on-a-Chip® platform technology can support your drug development programs. \nLink to Registration and Full Program \n\n\n 
URL:https://hesperosinc.com/event/cmt-summit-26-invited-talk/
LOCATION:Turf Valley Resort\, 2700 Turf Valley Road\, Ellicott City\, MD\, 21042\, United States
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/04/final-mdt-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260429
DTSTAMP:20260427T203307
CREATED:20260427T163409Z
LAST-MODIFIED:20260427T163409Z
UID:3712-1777248000-1777420799@hesperosinc.com
SUMMARY:Hesperos Presenting at Stanford Drug Discovery Symposium 2026
DESCRIPTION:Hesperos\, Inc. is excited to announce that our Chief Scientist\, James J. Hickman\, Ph.D.\, and Senior Scientist\, Kaveena Autar\, PhD\, are attending the Stanford Drug Discovery Symposium (SDDS 2026). This premier event brings together leading researchers\, industry professionals\, and innovators to discuss the latest breakthroughs and technologies in drug development. \nPoster Presentation: “In Vitro to In Vivo Translatability of Functional Human-on-a-Chip Systems for Digital Twin Modeling” \nKaveena will present Poster #10 that describes how Hesperos’ Human-on-a-Chip® (HoaC) single and multi-organ system platform models bridge the translational gap between preclinical discovery and predicted clinical outcomes to de-risk and accelerate development pipelines in a cost-effective manner. The research describes how integration of the HoaC platform models with advanced\, in silico\, pharmacokinetic/pharmacodynamic (PK/PD) digital twin modeling can better predict clinical dosing strategies from in vitro readouts. The poster showcases two compelling case studies: (1) an assessment of neurocognitive functional rescue using one of our CNS models and\, (2) accurate predictions of clinical dosing regimens using our multi-organ Malaria-on-a-Chip model. \nAbout our Team\nJames J. Hickman\, Ph.D.\, is Co-Founder and Chief Scientist at Hesperos\, Inc. He also is the Founding Director of the NanoScience Technology Center at the University of Central Florida. A pioneer in the MPS field\, Dr. Hickman\, has spent over 30 years developing functional in vitro systems. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE)\, the National Academy of Inventors\, and is the President of the International Microphysiological Systems Society (IMPSS). \nKaveena Autar\, PhD is a Senior Scientist\, her research focuses on the translatability of functional in vitro systems\, with particular emphasis on advanced neuronal studies. She has developed phenotypic models of human induced pluripotent stem cell (hiPSC)-derived cortical neurons to characterize network maturation and disease pathology. \nAttending SDDS 2026? We invite you to connect with J and Kaveena to discuss how Hesperos’ platform technology can support and accelerate your drug development programs in an expedient\, cost-effective manner.\n\nLink to the Full Program
URL:https://hesperosinc.com/event/hesperos-presenting-at-stanford-drug-discovery-symposium-2026/
LOCATION:Frances C. Arrillaga Alumni Center\, 326 Galvez St\, Stanford\, CA\, 94305\, United States
CATEGORIES:Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/04/SDDS2026-Graphic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260615
DTEND;VALUE=DATE:20260619
DTSTAMP:20260427T203307
CREATED:20260112T014113Z
LAST-MODIFIED:20260112T225840Z
UID:3471-1781481600-1781827199@hesperosinc.com
SUMMARY:PCRM Summer Immersion on Innovative Approaches in Science
DESCRIPTION:James J. Hickman\, Chief Scientist at Hesperos\, will be presenting at the upcoming Summer Immersion program hosted by Physicians Committee for Responsible Medicine in collaboration with Johns Hopkins Bloomberg School of Public Health. \nThis free\, four-day program focuses on New Approach Methodologies (NAMs)\, including our Human-on-a-Chip® platform\, and their application across basic\, translational\, and regulatory science. \nLearn more and apply here: https://www.pcrm.org/ethical-science/summer-immersion \n \n 
URL:https://hesperosinc.com/event/pcrm-summer-immersion-on-innovative-approaches-in-science/
LOCATION:Johns Hopkins Bloomberg School of Public Health\, Baltimore\, MD\, United States
CATEGORIES:Invited Speaker,Workshop
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/01/2026-Summer-Immersion_Horizontal_Logo.jpg
END:VEVENT
END:VCALENDAR